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In order to obtain an adequate impression of demarcation line area of a prepared 
tooth located in or below the gingival edge it is necessary to perform the dilatation and 
drying of the gingival sulcus using retraction cord impregnated with adequate retraction 
agents. The aim of the study was to carry out comparative analysis of advantages and 
disadvantages of commercially available gingival retraction agents. Commercial 
retraction agents include astringents (metal salts) and vasoconstrictors on the basis of 
epinephrine. Further research should be aimed at examining the possibility of using 
sympathomimetic vasoconstrictors (tetrahydrosolin and oxymetasolin) for gingival 
retraction. Acta Medica Medianae 2012; 51(1):81-84. 
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Introduction 
 
Appropriate impression taking for fixed dental 
appliances (crowns and bridges) involves precise 
impressing of the demarcation line area, which 
ensures perfect fitting of the marginal edges of 
artificial crown to teeth structures and reduces the 
possibility of marginal crevice appearance. The 
absence of discrepancy between prosthetic 
restoration and prepared tooth is required both for 
therapeutic purpose of using fixed dental prostheses, 
and for preventive purpose of arresting potential 
damage of hard dental tissue (1, 2).  
In order to take adequate impression of 
demarcation line area of a prepared tooth located in 
or below gingival edge it is necessary to perform 
gingival dilatation and drying. Firstly, tooth cervical 
region should be extricated as to enable impression 
material to penetrate the area between prepared 
dentin, that is, between tooth cement and wall of 
gingival sulcus (2,3). 
Mechanical-chemical gingival retraction repre-
sents one of the most frequently used methods (4). 
Mechanical component involves utilisation of 
retraction cord in order to ensure tissue 
compression and equal concentration of retraction 
agent in all parts of gingival sulcus. The depth of 
retraction cord is in the function of the gingival 
sulcus depth, depending on the patient's perio-
dontal status. The lack of application of chemical 
agents without mechanical support implies low 
efficiency for gingival pockets deeper than 2 mm 
(5). The use of retraction cord without impreg-
nation agent also shows lower therapeutic effect 
(5). 
The aim of the study was to carry out 
comparative analysis of advantages of commercially 
available gingival retraction agents.  
 
The role of retraction agents  
 
The role of retraction agent is temporary 
suppression of gingival tissue as well as 
haemorrhage control and gingival fluid flow, the 
balance of which is always disturbed after marginal 
tooth preparation (6,7). To be considered, an 
optimal a retraction agent should meet the 
following criteria (8): 
1.Efficiency implying providing substantial 
lateral and vertical recession of gingival tissue, 
haemorrhage control and gingival fluid flow. 
2. Utilisation of retraction agent must not 
significantly and permanently damage the surrounding 
tissue. Any manipulation and chemical treatment of 
tissue result in a certain sort of damage. However, 
this damage should be reversible, which means 
that it is followed by full clinical and histological 
recovery within 2 weeks. The ultimate apical 
gingival recession after mechanical and chemical 
retraction treatment must not exceed 0.1 mm. 
3. The absence of systemic effects, as a 
result of reabsorption of retraction agents into the 
surrounding tissue. The amount of reabsorbed 
materials depends on the type of retraction agent 
used, laceration of gingival tissue and the number 
of prepared teeth. 
The effect of conventional retraction agents 
may be astringent and vasoconstrictive (9, 10). 
 
Astringent retraction agents 
 
Astringents are metal salts that cause 
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inhibition of transcapilary movement of plasma 
proteins. They act by reducing cell permeability and 
drying surrounding tissue, leading to its reversible 
recession. Since precipitation of proteins in 
physiological conditions has antihaemorrhagic 
effect, astringensts are used as haemostatics. 
However, denatured proteins may lead to local 
tissue damage (6,7,11). 
Aluminum based retraction agents are 
considered to have astringent role, to be safe and 
moderately effective in suppressing gingival tissues. 
The most commonly used are aluminum chloride, 
aluminum sulfate and alum (potassium aluminum 
sulfate or aluminum ammonium sulfate). Concen-
trations of compounds are different and depend on 
the manufacturer. Research has shown potential 
toxicity of concentrations higher than 10% (3, 
12,13). 
Zinc chloride represents less commonly used 
astringent. Since it is caustic, too, the concentrations 
higher than 20% are not recommended for use (6). 
Unlike aluminum-based products, previously 
used ferrous sulfate produces no desired clinical 
results. Although it coagulates blood, haemorrhage 
often recurs after cord removal, the degree of 
tissue suppression is lower, and deepening of 
sulcus negligible. The disadvantages include irritative 
effects and tissue staining. The use of this agent in 
concentration greater than 20% is not allowed (11). 
Tissue damage is significantly higher in comparison 
with aluminum chloride (14). 
 
Vasoconstrictive retraction agents 
 
Epinephrine is one of the most commonly 
used retraction agents. It shows local hemodynamic 
effects and is very effective vasoconstrictor that 
activates sympathetic α1 receptors with peripheral 
blood vessels causing ischemic tissue reaction 
(7,15,16). In addition, local vasoconstriction results 
in a temporary and gingival recession (17). 
Although considered to be very effective agent, 
epinephrine may, however, lead to numerous side 
effects in a great number of patients, which 
significantly narrows its indication area. 
The maximum recommended dose of epi-
nephrine for cardiovascular patients is 0.04 mg, the 
amount approximately found in 2 capsules of local 
anaesthetic with a vasoconstrictor of 1:100000 
dilution. For healthy patients the maximum 
permitted dose of epinephrine is 0.2 mg (8,18). 
Absorption of epinephrine is different depending on 
the intactness of gingival epithelium. Madrid et al. 
showed that intact cervical gingival epithelium was 
effective barrier for epinephrine bound to plasma 
proteins (16). Each thread impregnated with 
epinephrine contains 0.2 to 1 mg of epinephrine, 
depending on the diameter and the manufacturer. 
It is 2.5 times higher dose of this vasoconstrictor 
recommended for healthy patients, and 12 times 
higher dose for cardiovascular patients, so that 
there is a great possibility of epinephrine overdose 
as a retraction agent (7). Kella et al. concluded that 
64% to 94% of epinephrine was absorbed from 
retraction cord to gingiva (19). The degree of 
resorption of retraction agent is greater if gingiva is 
lacerated during tooth grinding (17). 
The use of epinephrine represents the risk for 
patients treated with beta-blockers and antihyper-
tensive therapy (20). Its systemic absorption may 
lead to tachycardia, rapid breathing, hypertension, 
anxiety, feeling of weakness in the extremities, and 
depression (15,20). As a myocardial stimulant 
epinephrine accelerates heart rate, raises blood 
pressure (particularly systolic) and pulse rate. 
Epinephrine overdose may also result in ventricular 
tachycardia and potential fibrillation, angina attacks, 
myocardial and cerebrovascular infarction (8, 18). 
The use of epinephrine in case of gingival 
retraction is not recommended for patients with 
hyperthyroidism, or for depressive patients who are 
using monoamine oxidase inhibitors (tricyclic 
antidepressants) (20). In patients with diabetes 
mellitus resorbed epinephrine increases blood 
glucose levels (8). If reparation of the entire oral 
cavity is performed under total anesthesia, using 
fluorinated hydrocarbon based anaesthetic (e.g. 
halothane), the myocardium becomes more sensitive 
to the effects of epinephrine, which could endanger 
the patient's life. The use of epinephrine as a 
retraction agent in such cases is contraindicated (6, 
20). 
Since dental procedures have stressful effect 
on patients, a sudden increase of epinephrine level 
in blood may be expected even in healthy patients 
(21). If the retraction procedure is performed after 
administering local anaesthesia combined with 
adrenaline- based vasoconstrictor, the risk of organ 
damage induced by epinephrin-based retraction 
agent increases. A thorough history and under-
standing of pharmacological status of the patient 
are the only ways to prevent unwanted systemic 
effects of epinephrine-based retraction agents. 
Given the risk of cumulative effects of this 
vasoconstrictor and the fact that in everyday dental 
practice little is known about the general health of 
patients, and patients themselves are often not 
aware of their cardiovascular status, this type of 
retraction agent should generally be avoided. This 
is supported by the fact that the effect is almost 
identical when using epinephrine, aluminum chloride 
and aluminum sulfate for gingival recession (3, 6). 
Haemorrhage control is the only advantage of 
epinephrine compared to aluminum-based agents 
(6, 18). 
 
Alternative retraction agents 
 
Gingival retraction may cause damage to 
periodontal tissue (4, 10, 22). In order to find more 
appropriate retraction agents one should consider 
the possibility of using sympathomimetic vasocon-
strictors that are assumed to have desired efficacy 
without adverse local and systemic effects (23). 
Tetrahydrozoline and oxyimetazoline belong to 
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α agonists and are commercially available as nasal 
decongestive and eye drops. Systemic reactions to 
the use of these products are very rare, given that 
the maximum recommended doses are significantly 
higher than those required for effective gingival 
retraction (6). Studies by Bowles et al. showed a 
satisfactory clinical effect of tetrahydrozoline, 
strong local vasoconstrictive effect and the absence 
of systemic reactions (6). Clinical study by Tardy et 
al. demonstrated greater retraction efficiency of 
tetrahydrozoline without side-effects in relation to 
epinephrine  (24).  
 
Conclusion 
 
Retraction agents should provide adequate 
retraction thereby not giving any local or systemic 
side effects. Preference should be given to astringent 
agents based on metal salts as compared to 
epinephrine based agents regarding similar 
therapeutic effects and fewer adverse systemic 
effects. Further research should be aimed at 
examining the possibility of using sympa-
thomimetic vasoconstrictors (tetrahydrozoline and 
oxymetazoline) for gingival retraction.  
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UPOREDNI PREGLED SREDSTAVA ZA RETRAKCIJU GINGIVE 
 
Ivan Kostić, Stevo Najman, Milena Kostić i Sanja Stojanović 
 
 
U cilju adekvatnog otiskivanja predela demarkacione linije brušenog zuba, 
smeštene u ili ispod nivoa gingivalne ivice neophodna je dilatacija gingivalnog sulkusa i 
njegovo isušivanje upotrebom retrakcionog konca impegniranog adekvatnim 
retrakcionim  sredstvom. Cilj rada bio je uporedna analiza prednosti i nedostataka 
komercijalno dostupnih sredstava za retrakciju gingive. Komercijalna retrakciona 
sredstva obuhvataju adstrigense (soli metala) i vazokonstriktore na bazi epinefrina. 
Dalja istraživanja treba usmeriti ka  ispitivanju mogućnosti upotrebe simpatomimetskih 
vazokonstriktora (tetrahidrozolin i oksimetazolin) u svrhu retrakcije gingive. Acta 
Medica Medianae 2012;51(1):81-84. 
 
Ključne reči: retrakciona sredstva, tetrahidrozolin  
 